219 related articles for article (PubMed ID: 9647246)
1. Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains.
Roberts MR; Cooke KS; Tran AC; Smith KA; Lin WY; Wang M; Dull TJ; Farson D; Zsebo KM; Finer MH
J Immunol; 1998 Jul; 161(1):375-84. PubMed ID: 9647246
[TBL] [Abstract][Full Text] [Related]
2. Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes.
Tran AC; Zhang D; Byrn R; Roberts MR
J Immunol; 1995 Jul; 155(2):1000-9. PubMed ID: 7608531
[TBL] [Abstract][Full Text] [Related]
3. A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity.
Moritz D; Groner B
Gene Ther; 1995 Oct; 2(8):539-46. PubMed ID: 8593604
[TBL] [Abstract][Full Text] [Related]
4. Fc epsilonRI gamma can support T cell development and function in mice lacking endogenous TCR zeta-chain.
Shores E; Flamand V; Tran T; Grinberg A; Kinet JP; Love PE
J Immunol; 1997 Jul; 159(1):222-30. PubMed ID: 9200458
[TBL] [Abstract][Full Text] [Related]
5. TCR-gamma delta cells in CD3 zeta-deficient mice contain Fc epsilon RI gamma in the receptor complex but are specifically unresponsive to antigen.
Khattri R; Sperling AI; Qian D; Fitch FW; Shores EW; Love PE; Bluestone JA
J Immunol; 1996 Sep; 157(6):2320-7. PubMed ID: 8805629
[TBL] [Abstract][Full Text] [Related]
6. Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma.
Haynes NM; Snook MB; Trapani JA; Cerruti L; Jane SM; Smyth MJ; Darcy PK
J Immunol; 2001 Jan; 166(1):182-7. PubMed ID: 11123291
[TBL] [Abstract][Full Text] [Related]
7. Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product.
Finney HM; Lawson AD; Bebbington CR; Weir AN
J Immunol; 1998 Sep; 161(6):2791-7. PubMed ID: 9743337
[TBL] [Abstract][Full Text] [Related]
8. Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction.
Turatti F; Figini M; Balladore E; Alberti P; Casalini P; Marks JD; Canevari S; Mezzanzanica D
J Immunother; 2007 Oct; 30(7):684-93. PubMed ID: 17893561
[TBL] [Abstract][Full Text] [Related]
9. Expression of the zeta protein subunit in CD3- NK effectors derived from human thymus.
Beecher MS; Baiocchi RA; Linett ML; Krajewski CA; Caligiuri MA
Cell Immunol; 1994 May; 155(2):508-16. PubMed ID: 7514106
[TBL] [Abstract][Full Text] [Related]
10. Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo.
Schirrmann T; Pecher G
Cancer Gene Ther; 2002 Apr; 9(4):390-8. PubMed ID: 11960290
[TBL] [Abstract][Full Text] [Related]
11. A chimeric T cell receptor with super-signaling properties.
Petersen TR; Gülland S; Bettelli E; Kuchroo V; Palmer E; Bäckström BT
Int Immunol; 2004 Jul; 16(7):889-94. PubMed ID: 15148288
[TBL] [Abstract][Full Text] [Related]
12. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
[TBL] [Abstract][Full Text] [Related]
13. Developmental dissociation of T cells from B, NK, and myeloid cells revealed by MHC class II-specific chimeric immune receptors bearing TCR-zeta or FcR-gamma chain signaling domains.
Lin WY; Roberts MR
Blood; 2002 Oct; 100(8):3045-8. PubMed ID: 12351421
[TBL] [Abstract][Full Text] [Related]
14. Selective binding of shc-SH2 domain to tyrosine-phosphorylated zeta but not gamma-chain upon CD16 ligation on human NK cells.
Galandrini R; Palmieri G; Paolini R; Piccoli M; Frati L; Santoni A
J Immunol; 1997 Oct; 159(8):3767-73. PubMed ID: 9378963
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte development in the absence of CD3 epsilon or CD3 gamma delta epsilon zeta.
Wang B; Wang N; Whitehurst CE; She J; Chen J; Terhorst C
J Immunol; 1999 Jan; 162(1):88-94. PubMed ID: 9886373
[TBL] [Abstract][Full Text] [Related]
16. The TCR zeta-chain immunoreceptor tyrosine-based activation motifs are sufficient for the activation and differentiation of primary T lymphocytes.
Geiger TL; Leitenberg D; Flavell RA
J Immunol; 1999 May; 162(10):5931-9. PubMed ID: 10229830
[TBL] [Abstract][Full Text] [Related]
17. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
18. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
Altenschmidt U; Kahl R; Moritz D; Schnierle BS; Gerstmayer B; Wels W; Groner B
Clin Cancer Res; 1996 Jun; 2(6):1001-8. PubMed ID: 9816261
[TBL] [Abstract][Full Text] [Related]
19. T-cell killing of heterogenous tumor or viral targets with bispecific chimeric immune receptors.
Patel SD; Moskalenko M; Tian T; Smith D; McGuinness R; Chen L; Winslow GA; Kashmiri S; Schlom J; Stanners CP; Finer MH; McArthur JG
Cancer Gene Ther; 2000 Aug; 7(8):1127-34. PubMed ID: 10975673
[TBL] [Abstract][Full Text] [Related]
20. Sequential development of structural and functional alterations in T cells from tumor-bearing mice.
Correa MR; Ochoa AC; Ghosh P; Mizoguchi H; Harvey L; Longo DL
J Immunol; 1997 Jun; 158(11):5292-6. PubMed ID: 9164948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
